MFS
RLAY icon

Mirabella Financial Services’s Relay Therapeutics RLAY Stock Holding History

Mirabella Financial Services’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,121
Closed -$150K – 1087
2026
Q1 		$150K Buy
+15,121
New +$135K 0.01% 822
2020
Q4 		– Sell
-23,419
Closed -$997K – 458
2020
Q3 		$997K Buy
+23,419
New +$893K 0.14% 88

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Mirabella Financial Services's RLAY Position: Q2 2026 in Review

Mirabella Financial Services sold out of Relay Therapeutics (RLAY) in Q2 2026, closing a stake of 15,121 shares — an estimated $150K sold.

Mirabella Financial Services first reported a position in RLAY in Q3 2020 and held it in 2 quarters. The position peaked at $997K in Q3 2020. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Mirabella Financial Services reported no remaining Relay Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Mirabella Financial Services sold 15,121 Relay Therapeutics shares in Q2 2026, an estimated $150K.
  • Mirabella Financial Services first reported a position in Relay Therapeutics in Q3 2020 and held it in 2 quarters.
  • Mirabella Financial Services's Relay Therapeutics position peaked at $997K in Q3 2020.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Mirabella Financial Services's 13F filing for Q2 2026, filed 31 Jul 2026.